TY  - GEN
AU  - Jantus-Lewintre,Eloisa
AU  - Sarsotti,Elena
AU  - Terol,María José
AU  - Benet,Isabel
AU  - García-Conde,Javier
TI  - Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutations
SN  - 1699-048X
PY  - 2007///0424
KW  - ADP-ribosyl Cyclase 1
KW  - biosynthesis
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Amino Acid Chloromethyl Ketones
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Apoptosis
KW  - drug effects
KW  - Boronic Acids
KW  - Bortezomib
KW  - Caspase Inhibitors
KW  - Caspases
KW  - physiology
KW  - Cysteine Proteinase Inhibitors
KW  - Dose-Response Relationship, Drug
KW  - Drug Screening Assays, Antitumor
KW  - Female
KW  - Gene Rearrangement, B-Lymphocyte, Heavy Chain
KW  - Genes, Immunoglobulin
KW  - Humans
KW  - I-kappa B Kinase
KW  - antagonists & inhibitors
KW  - I-kappa B Proteins
KW  - metabolism
KW  - Immunoglobulin Heavy Chains
KW  - genetics
KW  - Immunoglobulin Variable Region
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - Male
KW  - Middle Aged
KW  - NF-kappa B
KW  - Neoplasm Proteins
KW  - Nitriles
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Protein Processing, Post-Translational
KW  - Protein-Tyrosine Kinases
KW  - Proto-Oncogene Proteins c-bcl-6
KW  - Pyrazines
KW  - Sulfones
KW  - Tumor Cells, Cultured
KW  - ZAP-70 Protein-Tyrosine Kinase
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s12094-006-0136-3
ER  -